Ivuxolimab | Interleukin Related interleukin-related.com

Product Name :
Ivuxolimab

Search keywords :
OX40L

drugId :
null

Target Vo:
Tumor necrosis factor receptor superfamily member 4

Target Vo Short Name :
OX40

Moa_Name:
Tumor necrosis factor receptor superfamily member 4 agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Array Biopharma

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PKC eta Antibody
Beta-Catenin Antibody
TRAF2 Antibody: TRAF2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to TRAF2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts